PSMA PET-CT Prostate Cancer Scans to Receive South Korean Health Insurance Coverage From September
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
News
From a news agency
Approved/passed
- South Korea will apply national health insurance coverage to PSMA PET-CT scans for assessing prostate cancer spread and recurrence.
- The coverage applies to PET-CT examinations using the PSMA-targeting radiopharmaceutical Prostacyc.
South Korea is entering an era of more precise prostate cancer imaging, with national health insurance coverage beginning in September for PSMA PET-CT examinations.
The scan helps assess whether prostate cancer has spread or returned. The coverage applies to PET-CT tests using Prostacyc, a radiopharmaceutical that targets prostate-specific membrane antigen, or PSMA.
About this summary
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
